Full Text View
Tabular View
Study Results
Related Studies
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
This study has been terminated.
( study was stopped due to low accrual )
Study NCT00924001   Information provided by National Institutes of Health Clinical Center (CC)

First Received on June 17, 2009.   Last Updated on October 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma
Malignant Melanoma
Melanoma, Experimental
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Experimental
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
DMF5 Melanoma Reactive TIL
Cyclophosphamide
Fludarabine
Aldesleukin
Additional drug interventions recognized in this trial
Fludarabine monophosphate
More general drug interventions related to this trial
Alkylating Agents
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Antiviral Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services